Describing readmissions to an ebola case management centre (CMC), Sierra Leone, 2014

Eurosurveillance

Volumn 19, Issue 40, 2014, Pages

  Fitzpatrick, G ^a,b   Vogt, F ^c   Moi Gbabai, O B ^d   Black, B ^c   Santantonio, M ^c   Folkesson, E ^c   Decroo, T ^a   Van Herp, M ^c  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^c MÉDECINS SANS FRONTIÈRES   (Belgium)

^d Ministry of Health and Sanitation   (Sierra Leone)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ASSESSMENT; COMMUNITY CARE; EBOLA HEMORRHAGIC FEVER; FEMALE; HOSPITAL INFECTION; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; SIERRA LEONE; WORLD HEALTH ORGANIZATION; YOUNG ADULT; CASE MANAGEMENT; CONTACT EXAMINATION; EPIDEMIC; HEMORRHAGIC FEVER, EBOLA; HOSPITAL ADMISSION; ORGANIZATION AND MANAGEMENT; STATISTICS AND NUMERICAL DATA;

CASE MANAGEMENT; CONTACT TRACING; DISEASE OUTBREAKS; HEMORRHAGIC FEVER, EBOLA; HUMANS; LENGTH OF STAY; PATIENT ADMISSION; PATIENT READMISSION; SIERRA LEONE;

EID: 84908042853     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.es2014.19.40.20924     Document Type: Article

References (12)

1. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, et al. Emergence of Zaire Ebola Virus Disease in Guinea. N Engl J Med. 2014;371(15):1418-25. http://dx.doi.org/10.1056/NEJMoa1404505
2. World Health Organization (WHO). Ebola response roadmap update. Geneva: WHO; Sep 2014. Available from: http://apps.who.int/iris/bitstream/10665/135029/1/roadmapupdate26sept14_eng.pdf
3. World Health Organization (WHO). Ebola response roadmap. Geneva: WHO; Aug 2014. Available from: http://www.who.int/csr/resources/publications/ebola/response-roadmap/en/
4. Ftika L, Maltezou HC. Viral haemorrhagic fevers in healthcare settings. J Hosp Infect. 2013;83(3):185-92. http://dx.doi.org/10.1016/j.jhin.2012.10.013
5. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377(9768):849-62. http://dx.doi.org/10.1016/S0140-6736(10)60667-8
6. MacNeil A, Rollin PE. Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Negl Trop Dis. 2012;6(6):e1546.
7. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 1999;179(Suppl 1):S87-91. http://dx.doi.org/10.1086/514284
8. World Health Organization (WHO). Case definition recommendations for Ebola or Marburg Virus Diseases. Geneva: WHO; Aug 2014. Available from: http://www.who.int/csr/resources/publications/ebola/ebola-case-definition-contact-en.pdf?ua=1
9. Sterk E. Filovirus haemorrhagic fever guideline. Geneva: Médecins Sans Frontières; 2008.
10. Kerstiëns B, Matthys F. Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl 1):S263-7. http://dx.doi.org/10.1086/514320
11. Wauquier N, Becquart P, Gasquet C, Leroy EM. Immunoglobulin G in Ebola outbreak survivors, Gabon. Emerg Infect Dis. 2009;15(7):1136-7. http://dx.doi.org/10.3201/eid1507.090402
12. Leroy EM, Gonzalez JP, Baize S. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect. 2011;17(7):964-76. http://dx.doi.org/10.1111/j.1469-0691.2011.03535.x